Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights strong financial performance, with increased revenue, billings, and free cash flow guidance. The company is confident in achieving its operating margin targets and has demonstrated growth across various sectors. Despite some vague responses in the Q&A, overall sentiment is positive, driven by strategic initiatives in AI, cloud, and platform development, as well as successful customer adoption and partnerships. The positive outlook for the second half of the year and improved shareholder returns further support a positive stock price reaction.
Total Revenue Grew 17% as reported and 18% in constant currency. The contribution from the new transaction model to revenue was approximately $105 million in the second quarter. Excluding the impact of the new transaction model, total revenue grew 11% in constant currency.
Billings Increased 36% as reported and 34% at constant currency, reflecting the shift to annual billings for most multiyear contracts and the transition to the new transaction model. The contribution from the new transaction model to billings was approximately $129 million in the second quarter. Excluding the impact of the new transaction model, billings grew 26% at constant currency.
RPO (Remaining Performance Obligations) RPO of $7.3 billion and current RPO of $4.7 billion grew 24% and 20%, respectively, benefiting from tailwinds from the new transaction model.
Operating Margins Second quarter GAAP and non-GAAP operating margins were 25% and 39%, respectively, reflecting year-over-year increases of 240 and 140 basis points, respectively. This reflected operating leverage, ongoing cost discipline, and some timing benefits from restructuring, partly offset by the margin drag from the new transaction model.
Free Cash Flow Second quarter free cash flow was $451 million, which benefited from the earlier timing of billings in the quarter.
Share Repurchase Purchased approximately 1.2 million shares for $356 million at an average price of approximately $298 per share. Year-to-date, repurchased 2.5 million shares for $709 million.
AI-powered Sketch AutoConstrain in Fusion: Delivered over 1.2 million dimensions since launch, with a 60% acceptance rate among commercial users and 90% of sketches fully constrained, providing substantial productivity gains.
Fusion with simulation, design, and data management extensions: Adopted by MotorScrubber to replace a competitive CAD solution, connecting disciplines, data, and workflows to drive efficiency and accelerate time to market.
Autodesk Construction Cloud: Adopted by Dynamic Energy to replace a competitive solution, addressing challenges with ERP integration, client billing, and forecasting.
Expansion in construction and manufacturing sectors: Sustained strong revenue and new customer momentum in construction, with Fusion driving strong growth in manufacturing.
Strategic engagement with Anna University, Chennai: Enhanced student employability through modern applied engineering education across 400+ affiliated colleges, supported by Autodesk's cloud-based platforms.
Go-to-market optimization plan: Remains on track, easing operational friction from the new transaction model implementation.
Increased operating margins: GAAP and non-GAAP operating margins increased by 240 and 140 basis points, respectively, due to operating leverage and cost discipline.
Focus on AI and generative design: Developing industry-specific foundation models and products, including Project Bernini, to redefine software and platforms with AI-driven CAD engines.
Hybrid consumption model: Adopted by an automotive manufacturer, combining named user subscriptions and Flex consumption tokens for scalable digital transformation.
Geopolitical, macroeconomic, and policy environment: Uncertainty in these areas could impact the company's ability to achieve its goals and maintain strong performance.
Softness in commercial sector: While there is strength in AECO, softness in the commercial sector could offset gains in other areas.
Operational friction from new transaction model: Although easing, the implementation of the new transaction model has caused operational friction, which could impact efficiency.
Macroeconomic uncertainty: Elevated uncertainty in the macroeconomic environment could affect the company's financial performance and strategic execution.
Tougher growth comparisons: The company will face tougher billings and revenue growth comparisons in the fourth quarter, which could challenge performance metrics.
Dependence on EBA renewals: A large pool of EBA renewals in the second half of the year introduces risk if these renewals do not materialize as expected.
Supply chain disruptions: Potential disruptions in the supply chain, as highlighted by a biopharmaceutical company example, could impact operations and customer satisfaction.
Regulatory compliance: Maintaining documentation and compliance in highly regulated industries, such as biopharmaceuticals, poses ongoing challenges.
Full Year Revenue Guidance: Raised to a range of $7.025 billion to $7.075 billion, reflecting strong business performance and additional FX tailwinds.
Billings Guidance: Increased to a range of $7.355 billion to $7.445 billion, driven by strong business momentum and operational improvements.
Non-GAAP Operating Margin Guidance: Raised to approximately 37% for fiscal '26, or 40% on an underlying basis excluding the impact of the new transaction model. Expected to reach 41% in fiscal '29, or 45% on an underlying basis.
Free Cash Flow Guidance: Increased by $88 million at the midpoint to a range of $2.2 billion to $2.275 billion for fiscal '26.
Share Buyback Targets: Raised by $100 million to a range of $1.2 billion to $1.3 billion for fiscal '26, representing a 40% to 50% increase compared to fiscal '25.
Macroeconomic Assumptions: The macroeconomic environment is broadly stable but uncertainty remains elevated. Guidance reflects cautious assumptions for the second half of the year.
Long-term Operating Margin Expansion: Expected to improve by approximately 500 basis points on a reported basis and 900 basis points on an underlying basis by fiscal '29, driven by efficiency gains and operating leverage.
Share Repurchase Program: We purchased approximately 1.2 million shares for $356 million at an average price of approximately $298 per share. Year-to-date, we have repurchased 2.5 million shares for $709 million. We've also raised our fiscal '26 share buyback targets by $100 million to between approximately $1.2 billion and $1.3 billion, which is a 40% to 50% increase compared to fiscal '25.
The earnings call summary and Q&A indicate strong financial performance, increased guidance, and positive business momentum. Raised revenue, billings, and share buyback targets signal confidence. The Q&A highlighted management's strategic focus on AI, automation, and margin expansion, although some uncertainties remain. Overall, the sentiment is positive, with potential for stock price growth.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.